Connect with us

Cannabis News

Health Canada cannabis guidance exposes “absurd” education gap in healthcare

Published

3 weeks ago

on

New federal guidance on medical cannabis is drawing attention to a growing gap in Canadian health care: patients are increasingly using cannabis to manage symptoms, but often without consistent clinical education, dosage support or drug interaction screening.

In January 2026, Health Canada published Information on the Medical Uses of Cannabis, a guidance document for consumers that includes contraindications, possible drug interactions, dosing and titration principles, and potential adverse effects.

Legal cannabis products produced and sold in Canada are not licensed to treat specific diseases or symptoms and have not been reviewed to determine whether they are safe or effective for those purposes.

“This is top-to-bottom healthcare,” said Ajay Chahal, PharmD, co-founder of Apothecare. “Health Canada has done the work to put clear guidelines to Canadians, but it’s absurd that patients are still forced to be their own physician educators. We’ve created a reality where patients are forced to turn to budtenders for pseudo-clinical advice, product recommendations for sleep, pain, anxiety or cancer-related symptoms based on anecdotes that work for someone I know. That’s not informed care, it’s a symptom of a system that has failed.”

Health Canada says that the use of cannabis carries health risks that are not yet fully understood and advises Canadians to consult their health care provider before using cannabis for medical purposes.

“That warning should set the system in motion,” said Anushya Vijayaraghevan, PharmD, co-founder of Apothecare. “Patients should not gamble with their health to relieve symptoms. If a patient is taking antidepressants, blood thinners, seizure medications, or has mental health vulnerabilities, the stakes are real. However, patients are often left to make product decisions and trial-and-error dosing with little guidance from the clinical system they are supposed to protect.”

In response to Health Canada’s guidelines, Apothecare is calling for four immediate actions to close the cannabis education gap in Canadian healthcare. First, medical cannabis education should be integrated into the core training of physicians, pharmacists, nurses, and allied health providers, with standardized learning outcomes that address dosage, contraindications, impairment, and drug interactions. Cannabis is already being used by patients across the country, and clinicians need a shared baseline of knowledge to manage it safely and consistently.

Second, clinical cannabis counseling should be established as a standard for patient safety. Canadians deserve access to evidence-based guidance that is medically responsible, consistent across care settings and independent of retail environments. Without clinical advice, patients are often left to navigate complex decisions on their own, increasing the risk of misuse, adverse effects, or missed interactions with other therapies.

Third, continuing education requirements through professional organizations need to be modernized so that clinicians can keep pace as cannabis use becomes more common for symptom management. Continuing education allows health care providers to confidently counsel patients, analyze risk factors, and adapt care as evidence evolves, rather than relying on outdated information or comfort levels.

Finally, cannabis should be treated like other pharmacologically active therapies in routine care. This means standardizing patient disclosure, documenting use in medical records, and supporting appropriate follow-up and monitoring. By moving away from a trial-and-error approach, it will help integrate cannabis into standard care practices and improve patient safety and outcomes.

“This is not about being for or against cannabis,” Vijayaragheva said. “It’s about accountability. The system can’t ignore something this widespread and then act surprised when patients are confused, underinformed or harmed. We have the knowledge and the clinical space to do better, but it needs to be prioritized.”

“This should not be controversial,” Chahal said. “If millions of Canadians use cannabis for medical purposes, then millions of Canadians deserve professional-level education, consistent clinical supervision and clear safety standards.”

For more information:
Apothecare
https://apothecare.ca/

Related Topics:
Continue Reading

Cannabis News

Swiss company launches nationwide price comparison tool for cannabis

Published

6 hours ago

on

March 2, 2026

By











Evidena Care AG is one of the leading Swiss telemedicine platforms and specialized medical practices for medical cannabis. The company currently supports more than 2,000 patients across the country. Under the direction of Dr. Nicolai Berardi and two other specialist doctors, Evidena Care has focused on evidence-based, responsible and patient-centered treatment for the past two years.

Now, Evidena Care is launching a nationwide online comparison portal for medical cannabis products. The platform is designed for patients who already have a valid medical prescription and want a clear and reliable view of the market. For the first time in Switzerland, patients can directly compare products and prices from the country’s largest pharmacies in one place.

Medical cannabis plays an essential role in the treatment plans of many patients. At the same time, prices can vary significantly between pharmacies, even when the products contain the same levels of active ingredients. As these costs are often not covered by health insurance, or only partially covered, many patients have a heavy financial burden. The new portal addresses this issue by bringing transparency to a market that until now has been difficult to navigate.

The platform provides an overview of available products and dosages, clearly lists the active ingredient content, such as THC and CBD levels, and displays the current prices of leading Swiss pharmacies. Patients can directly compare options and make informed decisions that help optimize their therapy costs, without compromising medical guidance.

“Patients should not be victims of non-transparent pricing structures,” says Dr. Nicolai Berardi, CEO of Evidena Care AG. “We are creating transparency with our comparison portal, strengthening the self-responsibility of those affected and promoting fair competition in the interests of patients.”

The portal is only for people with a valid prescription. It serves as a true information tool and supports cost optimization in an existing therapy supervised by a physician.

For more information:
Evidena Care AG
Email: (email protected)
https://evidena.care/










Continue Reading

Cannabis News

Virginia Lawmakers Advance Marijuana Resentencing Bills As Push To Legalize Commercial Sales Also Nears Finish Line

Published

6 hours ago

on

March 2, 2026

By

Virginia’s House and Senate lawmakers have advanced a pair of bills with amendments that would allow people with prior marijuana convictions to be sentenced.

Members of the Senate and House Judiciary Committees on Monday approved alternate versions of the reform bill in opposite chambers, setting the stage for bicameral negotiations as the measures move through the legislative process.

Broadly, the legislation introduced in both chambers would create a process to consider changing the sentences for people incarcerated or on community supervision for certain crimes involving the possession, manufacture, sale or distribution of marijuana.

The Senate panel approved it HB 26 In a 9-6 vote by Del. Rozia Henson (D), with revisions largely consistent with the House bill, SB 62that is being backed by Senate President Pro Tem Louise Lucas (D). passed on the floor last month before going Home.

Senators have now referred the House measure to the Senate Finance and Appropriations Committee for further consideration.

There are some differences between the sizes of the chambers. The House-passed legislation includes minors who would be eligible for relief from marijuana-related convictions, clarifies that judges would only consider convictions for cannabis offenses and specifies that the reform would include people with marijuana-related probation violations.

Both proposed bills apply to people with convictions or convictions for conduct that occurred before July 1, 2021, when a state law legalizing personal possession and home cultivation of marijuana went into effect.




As for the Senate bill, which clean up The House committee’s 15-7 vote Monday would have eliminated more categories of people who could be eligible for the sentence as an alternative, and would add a longer list of violent crimes that make people with cannabis convictions ineligible for relief.

Against the background of these recent developments, Virginia bills to legalize the sale of recreational marijuana have moved forward in the way of implementing laws. Last week, members of the Chamber of Deputies and the Senate modified and advanced the proposals of the opposite chambers on the subject.

Members of the Virginia Legislature Last month, he took action on multiple marijuana bills during a major deadline—advance proposals to legalize the sale of cannabis, provide a way to punish previous marijuana convictions, as well as other laws to allow access to medical cannabis for seriously ill patients in hospitals.

Despite their stark differences, the two chambers’ trade sales bills have largely aligned with recommendations released by the legislature in December. Joint Committee to Oversee the Transition to the Commonwealth Retail Cannabis Market.

Meanwhile, some members of the GOP have aligned ideologically with their Democratic colleagues throughout this legislative process, breaking with the majority of their caucus. in favor of creating a regulated market for adults to buy cannabis.

Since legalizing cannabis ownership and home cultivation in 2021, Virginia lawmakers have been working to establish a commercial marijuana market– Only for those efforts to stall under former Gov. Glenn Youngkin (R), who twice vetoed measures sent to his desk by the Legislature.

Gov. Abigail Spanberger (D), on the other hand, supports legalizing the sale of marijuana to adults.

Separately last month, the Virginia House patients passed a bill to allow the use of medical marijuana in hospitals. It would require health care facilities to implement policies “to address the situation in which an eligible patient is authorized to use medical cannabis.”

The Senate passed various pieces of legislation use of medical cannabis in healthcare facilities last month

—
It’s Marijuana Time tracking hundreds of cannabis, psychedelic and drug policy bills in state legislatures and Congress this year. Patreon supporters by pledging at least $25/month, you’ll get access to our interactive maps, charts, and audio calendars so you never miss a development.

Learn more about our marijuana bill tracking and become a Patreon supporter to gain access
—

Meanwhile, the Virginia House passed the bill earlier this month Protecting the rights of parents who use marijuana by complying with state laws.

Del. According to the proposal by Nadarius Clark (D), a parent or guardian’s own use of cannabis “shall not serve as a basis for a finding of abuse or neglect of a child unless other facts establish that its possession or consumption causes or produces physical or mental injury to the child.”

“A person’s legal possession or consumption of substances permitted (under state marijuana law) shall not serve as a basis for limiting custody or visitation unless other facts establish that such possession or consumption is not in the best interest of the child,” reads the text of HB 942.

Separately, the Virginia Department of Labor and Industry has published a new defining workplace protections for cannabis users.

Marijuana Moment is made possible with the help of readers. If you rely on our pro-cannabis journalism to stay informed, consider a monthly Patreon pledge.

Become a patron on Patreon!

Continue Reading

Cannabis News

State counties could tax medical marijuana sales under a new House bill

Published

1 day ago

on

March 1, 2026

By











A bill that would allow Oklahoma counties to impose a tax on retail marijuana sales has passed a committee in the Oklahoma House of Representatives.

Under the Oklahoma Legislature, House Bill 3314, authored by Rep. Ryan Eaves, R-Atoka, would allow counties to impose a tax of 15 percent of the impact of public utilities within county boundaries. The bill is similar to Senate Bill 1125, introduced by state Sen. Dusty Deevers, R-Elgin, in the Oklahoma Senate during the 2025 legislative session. SB 1125 would allow counties and municipalities to levy an excise tax on medical marijuana.

HB3314 passed the House County and Municipal Government Committee on a 6-0 vote, and now moves to the Government Oversight Committee for further consideration. The invoice does not automatically generate tax. If a county chooses to join, it must first be approved by a majority of the county’s voters in a special election. The bill also exempts marijuana grown on private property by individuals and not sold.

“Countries are the ones dealing with the daily impact of marijuana sales,” Eaves said. “This allows local communities to decide for themselves whether they want to allocate a portion of that revenue to law enforcement, first responders and improving problem properties.”

Read more at News 9










Continue Reading
Advertisement

Trending

Copyright © 2021 The Art of MaryJane Media